These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 25500882)
1. Genetically engineered SCN5A mutant pig hearts exhibit conduction defects and arrhythmias. Park DS; Cerrone M; Morley G; Vasquez C; Fowler S; Liu N; Bernstein SA; Liu FY; Zhang J; Rogers CS; Priori SG; Chinitz LA; Fishman GI J Clin Invest; 2015 Jan; 125(1):403-12. PubMed ID: 25500882 [TBL] [Abstract][Full Text] [Related]
2. Bringing home the bacon? The next step in cardiac sodium channelopathies. Wilde AA; Postema PG J Clin Invest; 2015 Jan; 125(1):99-101. PubMed ID: 25500878 [TBL] [Abstract][Full Text] [Related]
3. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome. Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796 [TBL] [Abstract][Full Text] [Related]
4. Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/- hearts. Zhang Y; Guzadhur L; Jeevaratnam K; Salvage SC; Matthews GD; Lammers WJ; Lei M; Huang CL; Fraser JA Acta Physiol (Oxf); 2014 Aug; 211(4):559-73. PubMed ID: 24913289 [TBL] [Abstract][Full Text] [Related]
5. Genetic background determines the severity of age-dependent cardiac structural abnormalities and arrhythmia susceptibility in Scn5a-1798insD mice. Marchal GA; Rivaud MR; Wolswinkel R; Basso C; van Veen TAB; Bezzina CR; Remme CA Europace; 2024 Jun; 26(6):. PubMed ID: 38875491 [TBL] [Abstract][Full Text] [Related]
6. Normal interventricular differences in tissue architecture underlie right ventricular susceptibility to conduction abnormalities in a mouse model of Brugada syndrome. Kelly A; Salerno S; Connolly A; Bishop M; Charpentier F; Stølen T; Smith GL Cardiovasc Res; 2018 Apr; 114(5):724-736. PubMed ID: 29267949 [TBL] [Abstract][Full Text] [Related]
7. Variants in the SCN5A Promoter Associated With Various Arrhythmia Phenotypes. Yagihara N; Watanabe H; Barnett P; Duboscq-Bidot L; Thomas AC; Yang P; Ohno S; Hasegawa K; Kuwano R; Chatel S; Redon R; Schott JJ; Probst V; Koopmann TT; Bezzina CR; Wilde AA; Nakano Y; Aiba T; Miyamoto Y; Kamakura S; Darbar D; Donahue BS; Shigemizu D; Tanaka T; Tsunoda T; Suda M; Sato A; Minamino T; Endo N; Shimizu W; Horie M; Roden DM; Makita N J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27625342 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of SCN5A in mouse heart mimics human syndrome of enhanced atrioventricular nodal conduction. Liu GX; Remme CA; Boukens BJ; Belardinelli L; Rajamani S Heart Rhythm; 2015 May; 12(5):1036-45. PubMed ID: 25623181 [TBL] [Abstract][Full Text] [Related]
9. Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model. Leoni AL; Gavillet B; Rougier JS; Marionneau C; Probst V; Le Scouarnec S; Schott JJ; Demolombe S; Bruneval P; Huang CL; Colledge WH; Grace AA; Le Marec H; Wilde AA; Mohler PJ; Escande D; Abriel H; Charpentier F PLoS One; 2010 Feb; 5(2):e9298. PubMed ID: 20174578 [TBL] [Abstract][Full Text] [Related]
10. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters. Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399 [TBL] [Abstract][Full Text] [Related]
11. A transgenic zebrafish model of a human cardiac sodium channel mutation exhibits bradycardia, conduction-system abnormalities and early death. Huttner IG; Trivedi G; Jacoby A; Mann SA; Vandenberg JI; Fatkin D J Mol Cell Cardiol; 2013 Aug; 61():123-32. PubMed ID: 23791817 [TBL] [Abstract][Full Text] [Related]
12. Mannitol and hyponatremia regulate cardiac ventricular conduction in the context of sodium channel loss of function. Blair GA; Wu X; Bain C; Warren M; Hoeker GS; Poelzing S Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H724-H734. PubMed ID: 38214908 [TBL] [Abstract][Full Text] [Related]
13. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Meregalli PG; Tan HL; Probst V; Koopmann TT; Tanck MW; Bhuiyan ZA; Sacher F; Kyndt F; Schott JJ; Albuisson J; Mabo P; Bezzina CR; Le Marec H; Wilde AA Heart Rhythm; 2009 Mar; 6(3):341-8. PubMed ID: 19251209 [TBL] [Abstract][Full Text] [Related]
14. Refractory dispersion promotes conduction disturbance and arrhythmias in a Scn5a (+/-) mouse model. Martin CA; Grace AA; Huang CL Pflugers Arch; 2011 Oct; 462(4):495-504. PubMed ID: 21779762 [TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing identifies Y1495X of SCN5A to be associated with familial conduction disease and sudden death. Tan ZP; Xie L; Deng Y; Chen JL; Zhang WZ; Wang J; Yang JF; Yang YF Sci Rep; 2014 Jul; 4():5616. PubMed ID: 25010007 [TBL] [Abstract][Full Text] [Related]
16. Cardiac channelopathies associated with infantile fatal ventricular arrhythmias: from the cradle to the bench. Kato K; Makiyama T; Wu J; Ding WG; Kimura H; Naiki N; Ohno S; Itoh H; Nakanishi T; Matsuura H; Horie M J Cardiovasc Electrophysiol; 2014 Jan; 25(1):66-73. PubMed ID: 24112685 [TBL] [Abstract][Full Text] [Related]
17. Clinical Spectrum of Villarreal-Molina T; García-Ordóñez GP; Reyes-Quintero ÁE; Domínguez-Pérez M; Jacobo-Albavera L; Nava S; Carnevale A; Medeiros-Domingo A; Iturralde P Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052356 [TBL] [Abstract][Full Text] [Related]